[go: up one dir, main page]

MX2008016039A - Preparacion de glucano. - Google Patents

Preparacion de glucano.

Info

Publication number
MX2008016039A
MX2008016039A MX2008016039A MX2008016039A MX2008016039A MX 2008016039 A MX2008016039 A MX 2008016039A MX 2008016039 A MX2008016039 A MX 2008016039A MX 2008016039 A MX2008016039 A MX 2008016039A MX 2008016039 A MX2008016039 A MX 2008016039A
Authority
MX
Mexico
Prior art keywords
glucan
glucan preparations
preparations
relates
present
Prior art date
Application number
MX2008016039A
Other languages
English (en)
Inventor
Andrew MAGEE
James Rolke
Ren-Der Yang
Original Assignee
Biopolymer Engineering Inc Dba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopolymer Engineering Inc Dba filed Critical Biopolymer Engineering Inc Dba
Publication of MX2008016039A publication Critical patent/MX2008016039A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a composiciones que incluyen ß-glucano. Más particularmente la presente invención se refiere a un proceso para producir ß-glucano.
MX2008016039A 2006-06-15 2007-06-15 Preparacion de glucano. MX2008016039A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81397106P 2006-06-15 2006-06-15
PCT/US2007/014055 WO2007146416A2 (en) 2006-06-15 2007-06-15 Glucan preparations

Publications (1)

Publication Number Publication Date
MX2008016039A true MX2008016039A (es) 2009-07-10

Family

ID=38832560

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008016039A MX2008016039A (es) 2006-06-15 2007-06-15 Preparacion de glucano.

Country Status (11)

Country Link
US (3) US9610303B2 (es)
EP (1) EP2032180B1 (es)
JP (3) JP2009540106A (es)
CN (2) CN101553261B (es)
BR (1) BRPI0713734A2 (es)
CA (1) CA2655414C (es)
ES (1) ES2628021T3 (es)
IL (2) IL195937A (es)
MX (1) MX2008016039A (es)
RU (1) RU2490279C2 (es)
WO (2) WO2007146440A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (no) 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
US7514085B2 (en) * 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
EP1896600A2 (en) 2005-06-15 2008-03-12 Medimush A/S Anti-cancer combination treatment and kit-of-part
WO2006133708A1 (en) * 2005-06-15 2006-12-21 Medimush A/S Bioactive agents produced by submerged cultivation of a basidiomycete cell
BRPI0713734A2 (pt) 2006-06-15 2012-11-06 Biopolymer Engineering Inc Dba Biothera processo para a produção de beta-glucano solúvel, e, composição
WO2008027581A1 (en) * 2006-09-01 2008-03-06 University Of Louisville Mcrp antagonists and their uses
US20080167268A1 (en) * 2006-09-01 2008-07-10 Jun Yan Particulate beta-glucan compositions for regulating dendritic cells
CN101407559B (zh) * 2008-11-25 2011-01-26 天津科技大学 一种快速制备酵母β-1,3-葡聚糖的方法
FI20080665A0 (fi) * 2008-12-18 2008-12-18 Glykos Finland Oy Luonnollisen tyyppiset sakkaridikoostumukset
JP5172930B2 (ja) * 2009-10-20 2013-03-27 国立大学法人佐賀大学 高粘性培養液の粘性低下方法
US9943607B2 (en) 2011-05-09 2018-04-17 Biothera, Inc. Beta-glucan compounds, compositions, and methods
ES2869181T3 (es) 2011-06-03 2021-10-25 Hibercell Inc Métodos y preparaciones de beta-glucano opsonizado
EP2817012B1 (en) 2012-02-22 2024-12-04 Kemin Industries, Inc. Animal feed compositions and methods of using the same
US11229701B2 (en) 2012-04-30 2022-01-25 Hibercell, Inc. Methods for identifying beta-glucan binding to immune cells
EP3077816B1 (en) 2013-12-05 2021-03-24 Biothera, Inc. Beta-glucan assay methods
LT6145B (lt) 2014-04-14 2015-04-27 Uab "Biocentras" TERAPINĖ ß-GLIUKANŲ KOMPOZICIJA, MODULIUOJANTI ŽMOGAUS IMUNINĘ SISTEMĄ IR INICIJUOJANTI VĖŽINIŲ LĄSTELIŲ ARDYMĄ
ES2877099T3 (es) 2014-07-10 2021-11-16 Hibercell Inc Beta-glucano en combinación con agentes anticáncer que afectan al microambiente tumoral
WO2016073763A2 (en) 2014-11-06 2016-05-12 Biothera, Inc. Beta-glucan methods and compositions that affect the tumor microenvironment
MY181390A (en) 2014-11-19 2020-12-21 Tablemark Co Ltd Flavor improvement method for yeast cells and food quality imrproving agent
JP2016208909A (ja) * 2015-05-08 2016-12-15 株式会社カネカ 脂溶性生理活性物質の製造方法
JP6935877B2 (ja) * 2017-01-27 2021-09-15 日本製紙株式会社 免疫調整剤
WO2018156888A1 (en) 2017-02-24 2018-08-30 Biothera Pharmaceuticals, Inc. Beta glucan immunopharmacodynamics
AU2019234828B2 (en) 2018-03-13 2025-02-27 Hibercell, Inc. Beta glucan and CD40 agonist combination immunotherapy
JP6530846B1 (ja) * 2018-10-09 2019-06-12 アサヒグループホールディングス株式会社 免疫賦活剤及び感染予防方法
US11140912B1 (en) 2020-12-22 2021-10-12 Agvault, Llc Process for manufacturing yeast strains having increased mannan oligosaccharides and improved amino acid profiles
WO2023107712A1 (en) 2021-12-10 2023-06-15 Hibercell, Inc. SOLUBLE β-GLUCANS FOR INDUCING TRAINED IMMUNITY
CN115028755B (zh) * 2022-07-01 2023-08-11 福建省农业科学院食用菌研究所 一种高分子量绣球菌β-葡聚糖的制备方法

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810646A (en) * 1984-11-28 1989-03-07 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US5028703A (en) * 1988-03-11 1991-07-02 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5082936A (en) * 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5250436A (en) * 1984-11-28 1993-10-05 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
US5032401A (en) * 1989-06-15 1991-07-16 Alpha Beta Technology Glucan drug delivery system and adjuvant
CA2066172A1 (en) * 1989-09-08 1991-03-09 Alpha Beta Technology, Inc. Method for producing soluble glucans
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
US5622939A (en) 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
DE69030880T2 (de) * 1989-09-08 1997-09-18 Alpha Beta Technology Zusammensetzung zur Stimulierung des Immunsystems
US6143731A (en) * 1989-10-20 2000-11-07 The Collaborative Group, Ltd. Glucan dietary additives
US6020324A (en) * 1989-10-20 2000-02-01 The Collaborative Group, Ltd. Glucan dietary additives
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
JP2547220Y2 (ja) 1990-07-19 1997-09-10 株式会社ユニシアジェックス アクチュエータ
US5519009A (en) * 1993-10-01 1996-05-21 Donzis; Byron A. Solubilized yeast glucan
US5622940A (en) * 1994-07-14 1997-04-22 Alpha-Beta Technology Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US6214337B1 (en) * 1995-04-18 2001-04-10 Biotec Asa Animal feeds comprising yeast glucan
US6117850A (en) * 1995-08-28 2000-09-12 The Collaborative Group, Ltd. Mobilization of peripheral blood precursor cells by β(1,3)-glucan
US6090938A (en) * 1996-05-01 2000-07-18 Collaborative Group, Ltd. Activation of signal transduction by underivatized, aqueous soluble . .beta(1-3)-Glucan
US6110692A (en) * 1996-05-01 2000-08-29 The Collaborative Group, Ltd. Receptor for underivatized aqueous soluble β(1-3)-glucan
US6084092A (en) * 1997-01-31 2000-07-04 The Collaborative Group, Ltd. β(1-3)-glucan diagnostic assays
US6413715B2 (en) * 1997-01-31 2002-07-02 The Collaborative Group β(1-3)-glucan diagnostic assays
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
US6369216B1 (en) * 1998-09-25 2002-04-09 Biopolymer Engineering Pharmaceutical, Inc. Very high molecular weight β-glucans
AU6261999A (en) * 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
RU2233599C2 (ru) * 1998-10-26 2004-08-10 Себа Аб СПОСОБ ПОЛУЧЕНИЯ КОМПОЗИЦИИ, СОДЕРЖАЩЕЙ ВОДОРАСТВОРИМЫЙ β-ГЛЮКАН, (ВАРИАНТЫ) И ИЗГОТАВЛИВАЕМЫЕ ИЗ НЕЕ ПРОДУКТЫ
US6143883A (en) * 1998-12-31 2000-11-07 Marlyn Nutraceuticals, Inc. Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system
JP2001342257A (ja) * 2000-06-01 2001-12-11 Fuji Photo Film Co Ltd セルロース系ポリマーの製造方法
JP2002105101A (ja) * 2000-10-03 2002-04-10 Ajinomoto Co Inc 水溶性高分子の製造法
US7786094B2 (en) * 2001-10-09 2010-08-31 Biopolymer Engineering, Inc. Use of beta-glucans against biological warfare weapons and pathogens including anthrax
US20070042930A1 (en) * 2002-08-13 2007-02-22 Ross Gordon D Effect of beta-glucan on stem cell recruitment and tissue repair
WO2004014320A2 (en) * 2002-08-13 2004-02-19 Biopolymer Engineering, Inc. Methods of using beta glucan as a radioprotective agent
ATE462437T1 (de) * 2002-09-04 2010-04-15 Biopolymer Engineering Inc Krebstherapie mit ganzen glukan-teilchen und antikörpern
US20060165700A1 (en) * 2002-09-04 2006-07-27 Ostroff Gary R Cancer therapy using whole glucan particles and antibodies
CA2501820C (en) 2002-10-08 2009-12-15 Ricom Corporation Chitosan-containing polysaccharide, method for preparing the same and use thereof
WO2005078114A1 (ja) * 2004-02-13 2005-08-25 Alpron Co., Ltd. 酵母由来グルカンの製造方法
CN1964722A (zh) 2004-05-10 2007-05-16 生物聚合物工程有限公司 与抗生素、疫苗和病毒单克隆抗体组合的全葡聚糖颗粒
GB0411880D0 (en) 2004-05-27 2004-06-30 Imagination Tech Ltd Method and apparatus for efficient evaluation of "table-based" mathematical functions
FI20040804L (fi) * 2004-06-11 2005-12-12 Glubikan Ab Oy Menetelmä viljan ainesosan erottamiseksi
US20050020490A1 (en) * 2004-10-18 2005-01-27 Progressive Bioactives Incorporated A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals.
US20090214562A1 (en) * 2005-05-03 2009-08-27 Karel Steven J Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection
KR101372110B1 (ko) 2005-11-01 2014-03-14 씨피 켈코 유에스, 인코포레이티드 고점도 디우탄 검 및 제조 방법
BRPI0713734A2 (pt) 2006-06-15 2012-11-06 Biopolymer Engineering Inc Dba Biothera processo para a produção de beta-glucano solúvel, e, composição
US20090047288A1 (en) 2006-06-15 2009-02-19 Jun Yan Glucan compositions and methods of enhancing CR3 dependent neutrophil-mediated cytotoxicity
US20080167268A1 (en) * 2006-09-01 2008-07-10 Jun Yan Particulate beta-glucan compositions for regulating dendritic cells
WO2008027581A1 (en) * 2006-09-01 2008-03-06 University Of Louisville Mcrp antagonists and their uses
EP2146744A4 (en) 2007-04-24 2012-07-25 Univ Louisville Res Found THERAPEUTIC BETA-GLUCAN COMPOSITIONS
KR101665216B1 (ko) 2007-05-08 2016-10-11 바이오테라, 인크. 미립자-가용성 글루칸 제제
EP2200736B1 (de) 2007-10-08 2016-11-30 Basf Se Verfahren zur herstellung von formkörpern mit katalytischen eigenschaften als reaktoreinbauten

Also Published As

Publication number Publication date
US20080108114A1 (en) 2008-05-08
EP2032180B1 (en) 2017-03-15
US10272101B2 (en) 2019-04-30
HK1138215A1 (en) 2010-08-20
IL195937A0 (en) 2009-09-01
JP2014025079A (ja) 2014-02-06
RU2490279C2 (ru) 2013-08-20
EP2032180A4 (en) 2013-05-22
CA2655414A1 (en) 2007-12-21
AU2007258191A1 (en) 2007-12-21
CN101553261A (zh) 2009-10-07
CN103833867A (zh) 2014-06-04
IL195937A (en) 2016-04-21
EP2032180A2 (en) 2009-03-11
CA2655414C (en) 2019-04-23
JP2009540106A (ja) 2009-11-19
WO2007146440A2 (en) 2007-12-21
JP6196280B2 (ja) 2017-09-13
WO2007146416A2 (en) 2007-12-21
US20080103112A1 (en) 2008-05-01
RU2009101051A (ru) 2010-07-20
BRPI0713734A2 (pt) 2012-11-06
WO2007146440A3 (en) 2008-02-07
US9610303B2 (en) 2017-04-04
WO2007146416A3 (en) 2008-03-13
WO2007146440B1 (en) 2008-03-20
ES2628021T3 (es) 2017-08-01
IL236842A (en) 2017-04-30
CN101553261B (zh) 2014-01-29
JP5851472B2 (ja) 2016-02-03
WO2007146416B1 (en) 2008-04-24
CN103833867B (zh) 2017-07-04
US20170304352A1 (en) 2017-10-26
JP2016053080A (ja) 2016-04-14

Similar Documents

Publication Publication Date Title
MX2008016039A (es) Preparacion de glucano.
TW200736181A (en) Anti-reflective coatings
WO2009074875A8 (en) Sound-absorbing, resistant panels and process for making same
MY150971A (en) Mineral amino acid polysaccharide complex
EA200970580A1 (ru) Таннат разагилина
MX2009007146A (es) Conjugados porcion del factor ix-polimero que tienen ligadura que se puede liberar.
TW200745261A (en) Aqueous dispersions based on nitrocellulose-polyurethane particles
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
WO2007093627A3 (de) Biozide zusammensetzung
MX2010002403A (es) Metodo y composicion para elaborar una forma de dosificacion que se desintegra por via oral.
MX2010008779A (es) Sistemas de productos estables en almacenamiento para formulaciones de pre-mezcla.
WO2008009831A3 (fr) Derives de cyclodextrines amphiphiles
MX2011008621A (es) Proceso para la purificacion de lipopeptidos.
MX2009008660A (es) Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
MY149433A (en) Nutritional compositions containing punicalagins
TW200833649A (en) Method for the preparation of hydroxyadamantanamine
WO2008075205A3 (en) Improved process for the preparation of voriconazole
TW200727908A (en) Herbal composition for treating cancer
TW200732410A (en) Sprayable acoustic compositions
WO2009010377A3 (en) Process for preparing platelet-like (embossed) particles
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
TW200732345A (en) Niobium compound
MX2009004949A (es) Proceso para producir composiciones resistentes a la intemperie y productos obtenidos de los mismos.
MY146610A (en) Process of producing bleach boosters
UA91733C2 (ru) Способ получения кристаллической формы орлистата

Legal Events

Date Code Title Description
FG Grant or registration